Jason Bednar Analyst PerformanceSr. Research Analyst at Piper SandlerJason Bednar is a stock analyst at Piper Sandler focused in the medical sector, covering 19 publicly traded companies. Over the past year, Jason Bednar has issued 43 stock ratings, including buy and hold recommendations. While full access to Jason Bednar's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Bednar's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings78 Last 5 YearsBuy Recommendations71.23% 52 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution73RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Bednar.RatingPercentageCount Strong Buy0.0%0 ratings Buy71.2%52 ratings Hold28.8%21 ratings Sell0.0%0 ratingsOut of 73 total stock ratings issued by Jason Bednar at Piper Sandler, the majority (71.2%) have been Buy recommendations, followed by 28.8% Hold.Best & Worst CallsBest Call000.0%EDAPMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%LUNGMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ78.9% of companies on NASDAQ15 companiesNYSE21.1% of companies on NYSE4 companiesJason Bednar, an analyst at Piper Sandler, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical18 companies94.7%Manufacturing1 company5.3%Jason Bednar of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED/DENTAL - SUPP6 companies31.6%MED PRODUCTS3 companies15.8%MED INSTRUMENTS3 companies15.8%MEDICAL SERVICES2 companies10.5%MEDICAL INFO SYS2 companies10.5%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company5.3%MED - BIOMED/GENE1 company5.3%DENTAL EQUIPMENT & SUPPLIES1 company5.3% About Jason BednarJason Bednar is a managing director and senior research analyst at Piper Sandler focused on the medical technology sector. Prior to joining Piper Sandler in 2020, he spent more than 11 years in medical technology equity research at Robert W. Baird & Co. Bednar holds a Master of Business Administration degree from the University of Chicago Booth School of Business and a bachelor of science degree in finance from Marquette University. Bednar is also a CFA Charterholder. Follow on LinkedIn Jason Bednar's Ratings History at Piper Sandler Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSHCSotera Health5/6/2026Reiterated Rating$15.78$22.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies4/30/2026Lower Price Target$60.46$74.00$0.0000.00% ROIALGNAlign Technology4/21/2026Boost Price Target$191.66$235.00Overweight$0.0000.00% ROISOLVSolventum4/17/2026Lower Price Target$68.82$92.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems4/17/2026Lower Price Target$70.10$96.00Overweight$0.0000.00% ROIICUIICU Medical4/17/2026Lower Price Target$126.04$163.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies4/17/2026Lower Price Target$73.20$88.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company4/17/2026Lower Price Target$154.89$159.00Neutral$0.0000.00% ROIDRTSAlpha Tau Medical3/4/2026Reiterated Rating$7.07$5.00Neutral$0.0000.00% ROIICUIICU Medical2/20/2026Boost Price Target$149.74$178.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. MMSIMerit Medical Systems2/18/2026Lower Price Target$81.59$106.00Overweight$0.0000.00% ROIMASIMasimo2/17/2026Downgrade$174.50$180.00Hold$0.0000.00% ROIBDXBecton, Dickinson and Company2/10/2026Reiterated Rating$207.31$170.00Neutral$0.0000.00% ROINVSTEnvista2/6/2026Reiterated Rating$24.81$25.00Neutral$0.0000.00% ROIALGNAlign Technology2/5/2026Boost Price Target$161.30$220.00Overweight$0.0000.00% ROINVSTEnvista1/30/2026Boost Price Target$23.38$21.00Neutral$0.0000.00% ROIGEHCGE HealthCare Technologies1/30/2026Boost Price Target$78.78$94.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company1/28/2026Boost Price Target$203.41$205.00Neutral$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$50.00Overweight$0.0000.00% ROISHCSotera Health1/9/2026Upgrade$18.81$24.00Overweight$0.0000.00% ROISOLVSolventum12/17/2025Reiterated Rating$80.72Overweight$0.0000.00% ROICOOCooper Companies12/5/2025Reiterated Rating$77.03$94.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company11/7/2025Lower Price Target$177.44$190.00Neutral$0.0000.00% ROIICUIICU Medical11/7/2025Boost Price Target$129.67$172.00Overweight$0.0000.00% ROISOLVSolventum11/7/2025Boost Price Target$66.25$98.00Overweight$0.0000.00% ROISHCSotera Health11/5/2025Boost Price Target$16.07$17.00Neutral$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Reiterated Rating$87.85$109.00Overweight$0.0000.00% ROIALGNAlign Technology10/30/2025Reiterated Rating$147.68$200.00Overweight$0.0000.00% ROIALGNAlign Technology10/23/2025Reiterated Rating$136.02$190.00Overweight$0.0000.00% ROIICUIICU Medical9/10/2025Boost Price Target$130.57$153.00Overweight$0.0000.00% ROICOOCooper Companies8/28/2025Lower Price Target$64.90$83.00Overweight$0.0000.00% ROIICUIICU Medical8/15/2025Initiated Coverage$111.90$145.00Overweight$0.0000.00% ROISOLVSolventum8/8/2025Reiterated Rating$71.99$94.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company8/8/2025Reiterated Rating$187.49$200.00Neutral$0.0000.00% ROIMASIMasimo8/6/2025Boost Price Target$142.87$210.00Overweight$0.0000.00% ROINVSTEnvista8/1/2025Boost Price Target$18.89$19.00Neutral$0.0000.00% ROILUNGPulmonx7/31/2025Downgrade$3.15$2.50Neutral$0.0000.00% ROIMMSIMerit Medical Systems7/31/2025Lower Price Target$83.89$105.00Overweight$0.0000.00% ROIALGNAlign Technology7/31/2025Lower Price Target$140.24$190.00Overweight$0.0000.00% ROINVCRNovoCure6/27/2025Reiterated Rating$17.51$34.00Overweight$0.0000.00% ROICOOCooper Companies5/30/2025Reiterated Rating$67.82$105.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems5/23/2025Reiterated Rating$94.49$110.00Overweight$0.0000.00% ROISOLVSolventum5/19/2025Upgrade$74.08$87.00Overweight$0.0000.00% ROISOLVSolventum5/9/2025Lower Price Target$69.71$78.00Neutral$00.0000.00% ROIMASIMasimo5/7/2025Reiterated Rating$149.59$200.00Overweight$000.0000.00% ROIBDXBecton, Dickinson and Company5/2/2025Downgrade$169.56$185.00Neutral$000.0000.00% ROILUNGPulmonx5/1/2025Reiterated Rating$4.14$9.00Overweight$0.0000.00% ROIALGNAlign Technology5/1/2025Reiterated Rating$184.87$250.00Overweight$000.0000.00% ROIXRAYDENTSPLY SIRONA4/30/2025Lower Price Target$13.71$16.00Neutral$00.0000.00% ROIHSICHenry Schein4/30/2025Lower Price Target$64.71$77.00Overweight$00.0000.00% ROINVSTEnvista4/30/2025Lower Price Target$15.66$17.00Neutral$00.0000.00% ROISOLVSolventum4/30/2025Lower Price Target$65.66$80.00Neutral$00.0000.00% ROIMMSIMerit Medical Systems4/23/2025Lower Price Target$93.66$112.00Overweight$00.0000.00% ROIBDXBecton, Dickinson and Company4/23/2025Lower Price Target$203.92$260.00Overweight$000.0000.00% ROISHCSotera Health4/23/2025Lower Price Target$10.93$13.00Neutral$00.0000.00% ROINVCRNovoCure4/23/2025Lower Price Target$17.42$34.00Overweight$00.0000.00% ROIEDAPEdap Tms3/28/2025Lower Price Target$2.13$4.50Overweight$0.0000.00% ROIALGNAlign Technology3/18/2025Reiterated Rating$163.91$235.00Overweight$000.0000.00% ROICOOCooper Companies3/7/2025Reiterated Rating$84.04$115.00Overweight$00.0000.00% ROIMASIMasimo2/26/2025Boost Price Target$187.59$215.00Overweight$000.0000.00% ROIKRMDKORU Medical Systems2/14/2025Reiterated Rating$4.75$4.50Neutral$0.0000.00% ROIALGNAlign Technology2/6/2025Lower Price Target$216.36$270.00Overweight$000.0000.00% ROINVSTEnvista2/3/2025Boost Price Target$20.26$18.00Neutral$00.0000.00% ROIMMSIMerit Medical Systems1/29/2025Reiterated Rating$110.00$116.00Overweight$00.0000.00% ROIBDXBecton, Dickinson and Company1/28/2025Boost Price Target$248.55$280.00Overweight$000.0000.00% ROIMMSIMerit Medical Systems1/21/2025Boost Price Target$102.90$114.00Overweight$00.0000.00% ROIALGNAlign Technology10/17/2024Lower Price Target$216.05$285.00Overweight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
